- |||||||||| astegolimab (RG 6149) / Amgen, Roche
Enrollment closed, Enrollment change: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps (clinicaltrials.gov) - Feb 26, 2016 P1, N=41, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=84 --> 41
- |||||||||| Trial completion, Phase classification, Trial primary completion date: Sinopsys Lacrimal Stent Indicated for Sinus Irrigation (clinicaltrials.gov) - Feb 12, 2016
P0, N=9, Completed, Recruiting --> Active, not recruiting | N=84 --> 41 Active, not recruiting --> Completed | Phase classification: PN/A --> P0 | Trial primary completion date: Nov 2015 --> Feb 2016
- |||||||||| mometasone furoate nasal spray / Generic mfg.
Phase classification, Surgery: Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps (clinicaltrials.gov) - Feb 10, 2016 P2/3, N=100, Completed, Active, not recruiting --> Completed | Phase classification: PN/A --> P0 | Trial primary completion date: Nov 2015 --> Feb 2016 Phase classification: P3 --> P2/3
- |||||||||| Enrollment change, Trial termination, Trial primary completion date, Surgery: OASIS: Global Sinus Surgery Registry (clinicaltrials.gov) - Dec 15, 2015
P=N/A, N=269, Terminated, Trial primary completion date: Sep 2016 --> May 2017 N=2000 --> 269 | Recruiting --> Terminated | Trial primary completion date: May 2019 --> Nov 2015
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Sinonasal Gas Exchange Dynamics (clinicaltrials.gov) - Aug 20, 2015
P=N/A, N=12, Completed, N=200 --> 25 | Trial primary completion date: Feb 2013 --> Nov 2012 Recruiting --> Completed | N=45 --> 12 | Trial primary completion date: Dec 2015 --> Aug 2015
- |||||||||| Trial primary completion date: Sinusitis in Children and the Nasopharyngeal Microbiome (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=355, Recruiting, Recruiting --> Completed | N=45 --> 12 | Trial primary completion date: Dec 2015 --> Aug 2015 Trial primary completion date: Jan 2015 --> Dec 2016
- |||||||||| Enrollment closed: Sinus Balloon Dilation in Pediatric Patients (clinicaltrials.gov) - Aug 5, 2015
P=N/A, N=50, Active, not recruiting, Trial primary completion date: Jan 2015 --> Dec 2016 Recruiting --> Active, not recruiting
- |||||||||| Trial completion, Enrollment change: Reversal of Tobacco-Related Sinusitis (clinicaltrials.gov) - Mar 25, 2015
P=N/A, N=282, Completed, Not yet recruiting --> Recruiting | Initiation date: Apr 2014 --> Mar 2015 Active, not recruiting --> Completed | N=150 --> 282
- |||||||||| fluticasone / Generic mfg.
Enrollment open, Trial initiation date, Trial primary completion date, Surgery: Comparison of Nasal Steroids After FESS in CRSwNP (clinicaltrials.gov) - Jan 26, 2015 P=N/A, N=60, Recruiting, Withheld --> Recruiting | Phase classification: PN/A --> P3 Not yet recruiting --> Recruiting | Initiation date: Jul 2014 --> Jan 2015 | Trial primary completion date: Jan 2015 --> Jul 2015
- |||||||||| Xhance (fluticasone propionate intranasal spray) / OptiNose
Enrollment closed, Trial primary completion date: 12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device (clinicaltrials.gov) - Jan 26, 2015 P3, N=200, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Aug 2015
- |||||||||| Enrollment open, Trial initiation date, Trial primary completion date: Association of Periostin Levels and Chronic Sinusitis (clinicaltrials.gov) - Dec 7, 2014
P=N/A, N=30, Recruiting, Trial primary completion date: Oct 2013 --> Oct 2015 Not yet recruiting --> Recruiting | Initiation date: Feb 2014 --> Sep 2014 | Trial primary completion date: Dec 2014 --> Sep 2016
|